Codexis (CDXS) Cash from Investing Activities Growth (1y) (2011 - 2026)
Codexis (CDXS) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Codexis |
213.30 Mn |
148.16 Mn |
13.18 Mn |
-109.44% |
| Date | Value |
|---|
| Mar 31, 2026 |
-109.44% |
| Dec 31, 2025 |
299.55% |
| Sep 30, 2025 |
316.63% |
| Jun 30, 2025 |
98.65% |
| Mar 31, 2025 |
141.20% |
| Dec 31, 2024 |
-359.33% |
| Sep 30, 2024 |
238.48% |
| Jun 30, 2024 |
-1,624.19% |
| Mar 31, 2024 |
-769.76% |
| Dec 31, 2023 |
3,245.45% |
| Sep 30, 2023 |
15.43% |
| Jun 30, 2023 |
29.23% |
| Mar 31, 2023 |
67.43% |
| Dec 31, 2022 |
100.60% |
| Sep 30, 2022 |
88.10% |
| Jun 30, 2022 |
7.96% |
| Mar 31, 2022 |
-298.03% |
| Dec 31, 2021 |
-120.26% |
| Sep 30, 2021 |
-1,328.18% |
| Jun 30, 2021 |
-39.50% |
